Avadel Pharmaceuticals
Stock Forecast, Prediction & Price Target
Avadel Pharmaceuticals Financial Estimates
Avadel Pharmaceuticals Revenue Estimates
Avadel Pharmaceuticals EBITDA Estimates
Avadel Pharmaceuticals Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $0 N/A | $0 0% | $27.96M 0% | Avg: $298.29M Low: $253.26M High: $340.78M avg. 966.76% | Avg: $400.20M Low: $345.67M High: $448.12M avg. 34.16% | Avg: $478.26M Low: $413.10M High: $535.53M avg. 19.50% | Avg: $542.57M Low: $468.64M High: $607.54M avg. 13.44% |
Net Income
% change YoY
| $-77.32M N/A | $-137.46M -77.76% | $-160.27M -16.59% | Avg: $58.64M Low: $-2.40M High: $88.19M avg. 136.59% | Avg: $166.47M Low: $102.62M High: $176.38M avg. 183.86% | Avg: $172.85M Low: $142.23M High: $199.76M avg. 3.82% | Avg: $220.47M Low: $181.42M High: $254.79M avg. 27.55% |
EBITDA
% change YoY
| $-84.56M N/A | $-93.72M -10.82% | $-149.12M -59.11% | Avg: $-14.44M Low: $-16.50M High: $-12.26M avg. 90.31% | Avg: $-19.38M Low: $-21.70M High: $-16.74M avg. -34.16% | Avg: $-23.16M Low: $-25.93M High: $-20.00M avg. -19.50% | Avg: $-26.27M Low: $-29.42M High: $-22.69M avg. -13.44% |
EPS
% change YoY
| -$1.32 N/A | -$2.29 -73.48% | -$2 12.66% | Avg: $0.59 Low: -$0.03 High: $1.1 avg. 129.56% | Avg: $1.67 Low: $1.28 High: $2.2 avg. 182.02% | Avg: $2.16 Low: $1.77 High: $2.49 avg. 29.29% | Avg: $2.75 Low: $2.26 High: $3.18 avg. 27.55% |
Operating Expenses
% change YoY
| $85.59M N/A | $95.21M 11.23% | $164.96M 73.25% | Avg: $556.19M Low: $472.21M High: $635.40M avg. 237.15% | Avg: $746.19M Low: $644.52M High: $835.54M avg. 34.16% | Avg: $891.75M Low: $770.25M High: $998.53M avg. 19.50% | Avg: $1.01B Low: $873.81M High: $1.13B avg. 13.44% |
FAQ
What is Avadel Pharmaceuticals stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 87.95% in 2025-2028.
We have gathered data from 7 analysts. Their low estimate is -2.40M, average is 58.64M and high is 88.19M.
What is Avadel Pharmaceuticals stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 258.46% in 2025-2028.
We have gathered data from 7 analysts. Their low revenue estimate is $253.26M, average is $298.29M and high is $340.78M.
What is Avadel Pharmaceuticals stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 92.10% in 2025-2028.
We have gathered data from 7 analysts. Their low earnings per share estimate is -$0.03, average is $0.59 and high is $1.1.
What is the best performing analyst?
In the last twelve months analysts have been covering Avadel Pharmaceuticals stock. The most successful analyst is Francois Brisebois.